![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 38/2086 | (2013.01) | ||
C07K 16/18 | (2006.01) | ||
C07K2319/30 | (2013.01) | ||
C07K 14/54 | (2006.01) | ||
C07K 16/2863 | (2013.01) | ||
C07K 14/715 | (2006.01) | ||
A61K2039/505 | (2013.01) | ||
A61K 38/20 | (2006.01) | ||
C07K2317/732 | (2013.01) | ||
A61K 38/19 | (2006.01) | ||
A61P 37/06 | (2018.01) | ||
A61K 38/17 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 14/5443 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 14/7155 | (2013.01) | ||
A61P 37/06 | (2006.01) | ||
C07K 16/2896 | (2013.01) |
(11) | Patento numeris | 3601363 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18776459.2 |
Europos patento paraiškos padavimo data | 2018-03-30 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-02-05 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2018/025366 |
Data | 2018-03-30 |
(87) | Numeris | WO 2018/183821 |
Data | 2018-10-04 |
(30) | Numeris | Data | Šalis |
201762480339 P | 2017-03-31 | US | |
201815937493 | 2018-03-27 | US |
(72) |
SHRESTHA, Niraj , US
LIU, Bai , US
RHODE, Peter , US
WONG, Hing, C. , US
|
(73) |
Altor BioScience Corporation ,
2810 North Commerce Parkway, Miramar, Florida 33025,
US
|
(54) | ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES |
ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES |